PROTHENA CORP PLC (PRTA:NASDAQ)
$10.67 -0.12 (-1.1121%)
Analysed PROTHENA CORP PLC (PRTA:NASDAQ) News Sources
Prothena Announces Leadership Team Updates
10-04-2026
yahoo.com
AZN Posts Data From Hypophosphatasia Program on Efzimfotase Alfa
01-04-2026
yahoo.com
Top Growth Companies With High Insider Ownership In March 2026
31-03-2026
yahoo.com
Sanofi Gets EU Nod for Rezurock in Chronic Graft-Vs-Host Disease
31-03-2026
yahoo.com
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease
30-03-2026
yahoo.com
Why Is Sarepta Therapeutics (SRPT) Up 24.2% Since Last Earnings Report?
27-03-2026
yahoo.com
Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report?
26-03-2026
yahoo.com
Wall Street Analysts Think Prothena (PRTA) Could Surge 120.19%: Read This Before Placing a Bet
26-03-2026
yahoo.com
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
21-03-2026
yahoo.com
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy
09-03-2026
yahoo.com
What is the current price of PROTHENA CORP PLC (PRTA:NASDAQ)?
The current price of PROTHENA CORP PLC (PRTA:NASDAQ) is $10.67.
PROTHENA CORP PLC (PRTA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROTHENA CORP PLC (PRTA:NASDAQ) since the previous trading day is $-0.12.
PROTHENA CORP PLC (PRTA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROTHENA CORP PLC (PRTA:NASDAQ) since the previous trading day is -1.1121%.
What is the most recent average sentiment score for PROTHENA CORP PLC (PRTA:NASDAQ)?
The most recent average sentiment score for PROTHENA CORP PLC (PRTA:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for PROTHENA CORP PLC (PRTA:NASDAQ)?
The most recent sentiment for PROTHENA CORP PLC (PRTA:NASDAQ) is .
SEC-8K** Filing Available For PROTHENA CORP PLC (PRTA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.